A recent study shows that the majority of women treated for breast cancer returned to their prediagnosis working time.

Chemotherapy is increasingly being given as "maintenance" therapy, continuing the regimen even after the cancer is under control, as a preventive strategy, according to a recent report in the New York Times. This approach is being used for ovarian cancer, multiple myeloma and non-Hodgkin's lymphoma. Here, Rosalie Canosa, a licensed clinical social